EveryONE Medicines
Michelle Mellion currently serves as the Chief Medical Officer at EveryONE Medicines, with responsibilities that include shaping clinical strategy, overseeing clinical trials, and ensuring regulatory compliance. In addition to this role, Michelle is a Medical Consultant for the FSHD Society. Prior experience includes leadership roles at PepGen as Chief Medical Officer and Senior Vice President, and at Fulcrum Therapeutics as Executive Medical Director, Head of Neuromuscular Clinical Development. Previous positions also include Medical Director at Vertex Pharmaceuticals and Assistant Professor of Neurology at Brown University. Michelle holds a Doctor of Medicine degree from Wake Forest University School of Medicine and a Bachelor of Arts in Molecular Biology from Colgate University.
This person is not in any teams
This person is not in any offices
EveryONE Medicines
EveryONE Medicines is committed to developing individualized precision medicines targeting genetic variants causing fatal, neurodegenerative diseases unique to just a few or even ONE patient. Momentum is building as technological advances with genomic testing and the prevalence of testing is improving rapidly to identify the rarest of rare mutations. Through a collaborative effort across all stakeholders in the treatment and diagnosis of rare genetic disease, EveryONE Medicines will bring a scalable solution to meet the needs of the individual patient who currently has limited hope.